Wellduphargrand Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-06-2024
- Paid Up Capital ₹ 0.10 M
as on 15-06-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -8.68%
(FY 2023)
- Ebitda
- Net Worth -10.58%
(FY 2023)
- Total Assets -2.55%
(FY 2023)
About Wellduphargrand Healthcare
The Corporate was formerly known as Jenricduphar Remedies Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Savita Pandey, Gopal Pandey, and Balaram Pandey serve as directors at the Company.
- CIN/LLPIN
U24239GJ2018PTC104509
- Company No.
104509
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Sep 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Wellduphargrand Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Savita Pandey  | Director | 30-Sep-2018 | Current |
| Gopal Pandey | Director | 30-Sep-2018 | Current |
| Balaram Pandey | Director | 30-Sep-2018 | Current |
Financial Performance of Wellduphargrand Healthcare.
Wellduphargrand Healthcare Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 8.68% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Wellduphargrand Healthcare?
In 2023, Wellduphargrand Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Primeshreya Remedies Private LimitedActive 6 years 2 monthsSavita Pandey, Gopal Pandey and 1 more are mutual person
- Shrishivay Sankatmochan Pharma Private LimitedActive 6 years 5 months
Savita Pandey, Gopal Pandey and 1 more are mutual person
- Solvy Remedies Private LimitedActive 6 years 6 months
Savita Pandey, Gopal Pandey and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wellduphargrand Healthcare?
Unlock and access historical data on people associated with Wellduphargrand Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wellduphargrand Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wellduphargrand Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
